Dengue virus capsid protein which induces a protective response and pharmaceutical composition

The invention relates to a method of obtaining the protein of the capsid of the serotypes of the Dengue virus, which can induce a protective immune response against a viral challenge in the recipient, without inducing antibody-dependent immunoamplification. The recombinant proteins obtained can be u...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GUILLEN NIETO, GERARDO ENRIQUE, GUZMAN TIRADO, MARIA GUADALUPE, LAZO VAZQUEZ, LAURA, VAZQUEZ RAMUNDO, SUSANA, HERMIDA CRUZ, LISSET, SIERRA VAZQUEZ, BEATRIZ DE LA CARIDAD, LOPEZ ABARRATEGUI, CARLOS, VALDEZ PRADO, IRIS, ZULUETA MORALES, AIDA
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a method of obtaining the protein of the capsid of the serotypes of the Dengue virus, which can induce a protective immune response against a viral challenge in the recipient, without inducing antibody-dependent immunoamplification. The recombinant proteins obtained can be used in the pharmaceutical industry in order to obtain dengue vaccine preparations.